NO20070983L - Stabil injiserbar blanding av alfa-tokoferylsuksinat, analoger og salter derav - Google Patents

Stabil injiserbar blanding av alfa-tokoferylsuksinat, analoger og salter derav

Info

Publication number
NO20070983L
NO20070983L NO20070983A NO20070983A NO20070983L NO 20070983 L NO20070983 L NO 20070983L NO 20070983 A NO20070983 A NO 20070983A NO 20070983 A NO20070983 A NO 20070983A NO 20070983 L NO20070983 L NO 20070983L
Authority
NO
Norway
Prior art keywords
analogs
alpha
salts
tocopheryl succinate
stable injectable
Prior art date
Application number
NO20070983A
Other languages
English (en)
Inventor
Andrew Xian Chen
Original Assignee
Sd Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sd Pharmaceuticals Inc filed Critical Sd Pharmaceuticals Inc
Publication of NO20070983L publication Critical patent/NO20070983L/no

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • A61K9/127Liposomes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/337Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having four-membered rings, e.g. taxol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/3533,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A61K31/355Tocopherols, e.g. vitamin E
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • A61K9/107Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • A61P35/02Antineoplastic agents specific for leukemia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Dispersion Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Dermatology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Oncology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

Foreliggende oppfinnelse tilveiebringer sammensetninger som omfatter alfatokoferylsuksinat eller dens analog eller salt og fremgangsmåter for fremstilling av og anvendelse av slike sammensetninger.
NO20070983A 2004-07-28 2007-02-21 Stabil injiserbar blanding av alfa-tokoferylsuksinat, analoger og salter derav NO20070983L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US59209704P 2004-07-28 2004-07-28
PCT/US2005/026783 WO2006015120A2 (en) 2004-07-28 2005-07-28 Stable injectable composition of alpha tocopheryl succinate, analogues and salts thereof

Publications (1)

Publication Number Publication Date
NO20070983L true NO20070983L (no) 2007-02-27

Family

ID=35787824

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20070983A NO20070983L (no) 2004-07-28 2007-02-21 Stabil injiserbar blanding av alfa-tokoferylsuksinat, analoger og salter derav

Country Status (11)

Country Link
US (1) US20060024360A1 (no)
EP (1) EP1778217A4 (no)
JP (1) JP2008508302A (no)
KR (1) KR20070059072A (no)
CN (1) CN1925853B (no)
AU (1) AU2005269383A1 (no)
CA (1) CA2575216A1 (no)
IL (1) IL180741A0 (no)
NO (1) NO20070983L (no)
RU (1) RU2007107359A (no)
WO (1) WO2006015120A2 (no)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7871632B2 (en) * 2004-07-12 2011-01-18 Adventrx Pharmaceuticals, Inc. Compositions for delivering highly water soluble drugs
US8557861B2 (en) 2004-09-28 2013-10-15 Mast Therapeutics, Inc. Low oil emulsion compositions for delivering taxoids and other insoluble drugs
US20080038316A1 (en) * 2004-10-01 2008-02-14 Wong Vernon G Conveniently implantable sustained release drug compositions
TWI376239B (en) * 2006-02-01 2012-11-11 Andrew Xian Chen Vitamin e succinate stabilized pharmaceutical compositions, methods for the preparation and the use thereof
CN101011355B (zh) * 2006-02-01 2013-01-02 陈献 经维生素e琥珀酸酯稳定的医药组合物、其制备及用途
WO2007139930A2 (en) * 2006-05-26 2007-12-06 Bayer Healthcare Llc Drug combinations with substituted diaryl ureas for the treatment of cancer
CA2663474C (en) 2006-09-15 2017-06-27 Griffith University Pro-oxidant anti-cancer compounds
NZ555163A (en) * 2007-05-14 2010-05-28 Fonterra Co Operative Group Methods of immune or hematological enhancement, inhibiting tumour formation or growth, and treating or preventing cancer, cancer symptoms, or the symptoms of cancer treatments
MX2009013663A (es) * 2007-06-22 2010-01-27 Scidose Llc Formulacion solubilizada de docetaxel sin tween 80.
EP2265623B1 (en) 2008-03-14 2016-07-13 Cancure Limited Mitochondrially delivered anti-cancer compounds
US20100260830A1 (en) * 2009-04-08 2010-10-14 Brian A Salvatore Liposomal Formulations of Tocopheryl Amides
US8568745B2 (en) 2009-07-09 2013-10-29 Kyushu University, National University Corporation Water-soluble drug carrier and process for producing the same
WO2011019710A2 (en) * 2009-08-10 2011-02-17 Proviflo, Llc Catheter lock solutions utilizing tocopheraol and mid-chain fatty acids
JP2013503166A (ja) * 2009-08-25 2013-01-31 カーディオカイン・バイオファーマ・エルエルシー 不溶性剤を送達するための組成物
US8476310B2 (en) 2009-10-19 2013-07-02 Scidose Llc Docetaxel formulations with lipoic acid
US7772274B1 (en) 2009-10-19 2010-08-10 Scidose, Llc Docetaxel formulations with lipoic acid
US20110092579A1 (en) * 2009-10-19 2011-04-21 Scidose Llc Solubilized formulation of docetaxel
US8541465B2 (en) * 2009-10-19 2013-09-24 Scidose, Llc Docetaxel formulations with lipoic acid and/or dihydrolipoic acid
US8912228B2 (en) 2009-10-19 2014-12-16 Scidose Llc Docetaxel formulations with lipoic acid
UA110383C2 (en) * 2011-06-08 2015-12-25 Akzo Nobel Chemicals Int Bv Deicing composition
PL2718386T3 (pl) 2011-06-08 2016-07-29 Akzo Nobel Chemicals Int Bv Kompozycja przeciwoblodzeniowa
AR088524A1 (es) 2011-11-09 2014-06-18 Akzo Nobel Chemicals Int Bv Composicion descongelante, proceso de preparacion, conjunto de parte y uso
RU2664700C2 (ru) 2012-05-10 2018-08-21 Пейнреформ Лтд. Депо-составы местного анестетика и способы их получения
JP6094388B2 (ja) * 2013-06-07 2017-03-15 ニプロ株式会社 ペメトレキセドを含む注射用組成物
JP6087769B2 (ja) * 2013-08-30 2017-03-01 サントリー食品インターナショナル株式会社 烏龍茶抽出物を含有する容器詰飲料
WO2016201269A2 (en) 2015-06-11 2016-12-15 Proviflo, Llc Graft-port hemodialysis systems, devices and methods
US11229602B2 (en) * 2016-01-07 2022-01-25 Western University Of Health Sciences Formulations for treating bladder cancer
US20200138855A1 (en) * 2017-07-20 2020-05-07 Delta-Fly Pharma, Inc. Novel antineoplastic drug based on specificity of cancer-cell metabolism

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3173838A (en) * 1962-03-28 1965-03-16 Eastman Kodak Co Solid, vitamin e-active product and process for making it
US4783220A (en) * 1986-12-18 1988-11-08 Xerox Corporation Vesicle ink compositions
CA2130357A1 (en) * 1992-02-18 1993-08-19 Doron Friedman Dry compositions for preparing submicron emulsions
US5961970A (en) * 1993-10-29 1999-10-05 Pharmos Corporation Submicron emulsions as vaccine adjuvants
GB9409778D0 (en) * 1994-05-16 1994-07-06 Dumex Ltd As Compositions
GB9514878D0 (en) * 1995-07-20 1995-09-20 Danbiosyst Uk Vitamin E as a solubilizer for drugs contained in lipid vehicles
US6727280B2 (en) * 1997-01-07 2004-04-27 Sonus Pharmaceuticals, Inc. Method for treating colorectal carcinoma using a taxane/tocopherol formulation
US6458373B1 (en) * 1997-01-07 2002-10-01 Sonus Pharmaceuticals, Inc. Emulsion vehicle for poorly soluble drugs
US7030155B2 (en) * 1998-06-05 2006-04-18 Sonus Pharmaceuticals, Inc. Emulsion vehicle for poorly soluble drugs
US20030236236A1 (en) * 1999-06-30 2003-12-25 Feng-Jing Chen Pharmaceutical compositions and dosage forms for administration of hydrophobic drugs
US20030005407A1 (en) * 2000-06-23 2003-01-02 Hines Kenneth J. System and method for coordination-centric design of software systems
US20030099674A1 (en) * 2001-08-11 2003-05-29 Chen Andrew X. Lyophilized injectable formulations containing paclitaxel or other taxoid drugs
US20040175415A1 (en) * 2003-03-05 2004-09-09 Chan Alvin C. Formulations and methods of delivery of intact tocopheryl succinate to humans
US7871632B2 (en) * 2004-07-12 2011-01-18 Adventrx Pharmaceuticals, Inc. Compositions for delivering highly water soluble drugs

Also Published As

Publication number Publication date
KR20070059072A (ko) 2007-06-11
JP2008508302A (ja) 2008-03-21
CA2575216A1 (en) 2006-02-09
CN1925853A (zh) 2007-03-07
IL180741A0 (en) 2007-07-04
EP1778217A4 (en) 2008-10-08
WO2006015120A3 (en) 2006-05-18
RU2007107359A (ru) 2008-09-10
US20060024360A1 (en) 2006-02-02
EP1778217A2 (en) 2007-05-02
AU2005269383A1 (en) 2006-02-09
WO2006015120A2 (en) 2006-02-09
CN1925853B (zh) 2011-01-26

Similar Documents

Publication Publication Date Title
NO20070983L (no) Stabil injiserbar blanding av alfa-tokoferylsuksinat, analoger og salter derav
WO2018136202A3 (en) Compounds and methods for cdk8 modulation and indications therefor
UA112281C2 (uk) Стабільні інсектицидні композиції і способи їх отримання
SV2004001690A (es) Nuevos derivados de fluoroglicosidos heterociclicos, medicamentos que contienen estos compuestos, y el uso de los mismos
CY1114539T1 (el) Η χρησιμοτητα των ιμιδαζοπυριδαζινοκαρβονιτριλιων ως αναστολεων κινασων
MX2009003958A (es) Nuevos derivados de 1,4-benzotiepina-1,1-dioxido sustituidos con radicales bencilo, metodo para su preparacion, productos farmaceuticos que comprenden estos compuestos y su uso.
ATE433447T1 (de) Pyrimiidinverbindungen
ECSP099357A (es) COMPUESTOS QUE MODULAN ACTIVIDAD C-FMS y/o C-KIT Y USOS PARA ELLO
BRPI0514444A (pt) análogos de ciclopamina e métodos de uso destes
NO20071078L (no) Antivirale forbindelser
NO20070866L (no) Antivirale forbindelser.
NO20075082L (no) Pyridin-3-karboksamidderivater som CB1-inversagonister
DOP2010000396A (es) Derivado de uracilo o timina para el tratamiento de hepatitis c
NO20085183L (no) Stabiliserte insulinlignende vekstfaktorpolypeptider
TN2009000163A1 (en) Compounds and compositions as protein kinase inibitors
TW200642700A (en) Chemically defined stabiliser
NO20090295L (no) Substituerte heteroarylderivater
WO2012080284A3 (en) Substituted 6,6-fused nitrogenous heterocyclic compounds and uses thereof
NO20082023L (no) Pyrrolotriazin kinaseinhibitorer
ATE293119T1 (de) Cardioprotektive phosphonate
WO2008002571A3 (en) Human protein tyrosine phosphatase inhibitors and methods of use
NO20082124L (no) Bifenyloksyeddiksyrederivater for behandling av respiratorisk sykdom
NO20076638L (no) Nye 8-sulfonylamino-3-aminosubstituerte kroman- eller tetrahydronaftalenderivater som modulerer 5HT6-reseptoren
BRPI0608819B8 (pt) formas cristalinas de um derivado de imidazol
GT200600199A (es) Diarilsulfonas sulfonamidas y su uso

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application